Inhaled Nitric Oxide for Preterm Neonates

Clinics in Perinatology

Volumn 36, Issue 1, 2009, Pages 43-61

  Arul, Nandini ^a,b   Konduri, G Ganesh ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Children's Corporate Center   (United States)

Author keywords

Brain injury; Bronchopulmonary dysplasia; Inhaled nitric oxide; Preterm infants; Pulmonary hypertension

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITROGEN DIOXIDE; PEROXYNITRITE;

ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; BRAIN INJURY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; KNOCKOUT MOUSE; LONG TERM CARE; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG FUNCTION; METHEMOGLOBINEMIA; NEUROPROTECTION; NONHUMAN; PATIENT SELECTION; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; REVIEW; THROMBOCYTE AGGREGATION; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; NITRIC OXIDE; RESPIRATORY INSUFFICIENCY; RESPIRATORY SYSTEM AGENTS;

EID: 58249083209     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2008.09.002     Document Type: Review

References (99)

1. Ignarro L.J., Buga G.M., Wood K.S., et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84 (1987) 9265-9269
2. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
3. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group. N Engl J Med 336 (1997) 597-604
4. Clark R.H., Kueser T.J., Walker M.W., et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342 (2000) 469-474
5. Mourani P.M., Ivy D.D., Gao D., et al. Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. Am J Respir Crit Care Med 170 (2004) 1006-1013
6. Kinsella J.P., and Abman S.H. Inhaled nitric oxide in the premature infant: animal models and clinical experience. Semin Perinatol 21 (1997) 418-425
7. Kinsella J.P., Parker T.A., Galan H., et al. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 41 (1997) 457-463
8. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
9. Mercier J.C., and Franco-Belgium Neonatal Study Group on Inhaled Nitric Oxide. Uncertainties about the use of inhaled nitric oxide in preterm infants. Acta Paediatr Suppl 90 (2001) 15-18
10. Ignarro L.J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65 (1989) 1-21
11. Ignarro L.J., Cirino G., Casini A., et al. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 34 (1999) 879-886
12. Walter U. Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev Physiol Biochem Pharmacol 113 (1989) 41-88
13. Frostell C., Fratacci M.D., Wain J.C., et al. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83 (1991) 2038-2047
14. Coggins M.P., and Bloch K.D. Nitric oxide in the pulmonary vasculature. Arterioscler Thromb Vasc Biol 27 (2007) 1877-1885
15. Hughes M.N. Chemistry of nitric oxide and related species. Methods Enzymol. 436 (2008) 3-19
16. Han R.N., and Stewart D.J. Defective lung vascular development in endothelial nitric oxide synthase-deficient mice. Trends Cardiovasc Med. 16 (2006) 29-34
17. Parker T.A., le Cras T.D., Kinsella J.P., et al. Developmental changes in endothelial nitric oxide synthase expression and activity in ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 278 (2000) L202-L208
18. Shaul P.W., Afshar S., Gibson L.L., et al. Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol 283 (2002) L1192-L1199
19. Shaul P.W. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64 (2002) 749-774
20. Konduri G.G., Bakhutashvili I., Eis A., et al. Oxidant stress from uncoupled nitric oxide synthase impairs vasodilation in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol 292 (2007) H1812-H1820
21. Tristani-Firouzi M., Martin E.B., Tolarova S., et al. Ventilation-induced pulmonary vasodilation at birth is modulated by potassium channel activity. Am J Physiol 271 (1996) H2353-H2359
22. Shaul P.W. Nitric oxide in the developing lung. Adv Pediatr 42 (1995) 367-414
23. Young S.L., Evans K., and Eu J.P. Nitric oxide modulates branching morphogenesis in fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol 282 (2002) L379-L385
24. Balasubramaniam V., Tang J.R., Maxey A., et al. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol 284 (2003) L964-L971
25. Balasubramaniam V., Maxey A., and Abman S. Inhaled nitric oxide reverses hypoxia induced lung hypoplasia in endothelial nitric oxide synthase-deficient mice. Chest 128 (2005) 613S-614S
26. Balasubramaniam V., Maxey A.M., Morgan D.B., et al. Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. Am J Physiol Lung Cell Mol Physiol 291 (2006) L119-L127
27. Abman S.H., Kinsella J.P., Schaffer M.S., et al. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 92 (1993) 606-609
28. Kinsella J.P., Ivy D.D., and Abman S.H. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res 36 (1994) 402-408
29. Stahlman M., Blankenship W.J., Shepard F.M., et al. Circulatory studies in clinical hyaline membrane disease. Biol Neonate 20 (1972) 300-320
30. Evans N.J., and Archer L.N. Doppler assessment of pulmonary artery pressure during recovery from hyaline membrane disease. Arch Dis Child 66 (1991) 802-804
31. Skinner J.R., Boys R.J., Hunter S., et al. Pulmonary and systemic arterial pressure in hyaline membrane disease. Arch Dis Child 67 (1992) 366-373
32. Walther F.J., Benders M.J., and Leighton J.O. Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics 90 (1992) 899-904
33. Halliday H., Hirschfeld S., Riggs T., et al. Respiratory distress syndrome: echocardiographic assessment of cardiovascular function and pulmonary vascular resistance. Pediatrics 60 (1977) 444-449
34. Randala M., Eronen M., Andersson S., et al. Pulmonary artery pressure in term and preterm neonates. Acta Paediatr 85 (1996) 1344-1347
35. Golan A., Zalzstein E., Zmora E., et al. Pulmonary hypertension in respiratory distress syndrome. Pediatr Pulmonol 19 (1995) 221-225
36. Kumar V.H., Hutchison A.A., Lakshminrusimha S., et al. Characteristics of pulmonary hypertension in preterm neonates. J Perinatol 27 (2007) 214-219
37. Smyth R.L. Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure. Thorax 55 Suppl 1 (2000) S51-S55
38. Rossaint R., Falke K.J., Lopez F., et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328 (1993) 399-405
39. Rossaint R., Pison U., Gerlach H., et al. Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells. Eur Heart J 14 Suppl I (1993) 133-140
40. Williams O., Rafferty G.F., Hannam S., et al. Nasal and lower airway levels of nitric oxide in prematurely born infants. Early Hum Dev 72 (2003) 67-73
41. Leipala J.A., Williams O., Sreekumar S., et al. Exhaled nitric oxide levels in infants with chronic lung disease. Eur J Pediatr 163 (2004) 555-558
42. Zimmerman J.J. Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin Perinatol 22 (1995) 429-456
43. Ogden B.E., Murphy S., Saunders G.C., et al. Lung lavage of newborns with respiratory distress syndrome. Prolonged neutrophil influx is associated with bronchopulmonary dysplasia. Chest 83 (1983) 31S-33S
44. Kanwar S., and Kubes P. Nitric oxide is an antiadhesive molecule for leukocytes. New Horiz 3 (1995) 93-104
45. Gutierrez H.H., Nieves B., Chumley P., et al. Nitric oxide regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide. Free Radic Biol Med 21 (1996) 43-52
46. Hamon I., Fresson J., Nicolas M.B., et al. Early inhaled nitric oxide improves oxidative balance in very preterm infants. Pediatr Res 57 (2005) 637-643
47. Afshar S., Gibson L.L., Yuhanna I.S., et al. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 284 (2003) L749-L758
48. MacRitchie A.N., Albertine K.H., Sun J., et al. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol 281 (2001) L1011-L1020
49. Bland R.D., Albertine K.H., Carlton D.P., et al. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 172 (2005) 899-906
50. McCurnin D.C., Pierce R.A., Chang L.Y., et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 288 (2005) L450-L459
51. Tang J.R., Markham N.E., Lin Y.J., et al. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 287 (2004) L344-L351
52. Martin R.J., Mhanna M.J., and Haxhiu M.A. The role of endogenous and exogenous nitric oxide on airway function. Semin Perinatol 26 (2002) 432-438
53. Ballard P.L., Gonzales L.W., Godinez R.I., et al. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res 59 (2006) 157-162
54. Issa A., Lappalainen U., Kleinman M., et al. Inhaled nitric oxide decreases hyperoxia-induced surfactant abnormality in preterm rabbits. Pediatr Res 45 (1999) 247-254
55. Martin R.J., and Walsh M.C. Inhaled nitric oxide for preterm infants-who benefits?. N Engl J Med 353 (2005) 82-84
56. Cannon III R.O., Schechter A.N., Panza J.A., et al. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 108 (2001) 279-287
57. Mayhan W.G. Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res 866 (2000) 101-108
58. Martin R.J. Nitric oxide for preemies-not so fast. N Engl J Med 349 (2003) 2157-2159
59. Kinsella J.P., Cutter G.R., Walsh W.F., et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 355 (2006) 354-364
60. Viscardi R.M., Muhumuza C.K., Rodriguez A., et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 55 (2004) 1009-1017
61. Haynes R.L., Baud O., Li J., et al. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol 15 (2005) 225-233
62. Aaltonen M., Soukka H., Halkola L., et al. Inhaled nitric oxide treatment inhibits neuronal injury after meconium aspiration in piglets. Early Hum Dev 83 (2007) 77-85
63. Kinsella J.P., and Abman S.H. Inhaled nitric oxide in the premature newborn. J Pediatr 151 (2007) 10-15
64. Pawloski J.R., Hess D.T., and Stamler J.S. Export by red blood cells of nitric oxide bioactivity. Nature 409 (2001) 622-626
65. Steinhorn R.H., and Porta N.F. Use of inhaled nitric oxide in the preterm infant. Curr Opin Pediatr 19 (2007) 137-141
66. Peliowski A., Finer N.N., Etches P.C., et al. Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. J Pediatr 126 (1995) 450-453
67. Skimming J.W., Bender K.A., Hutchison A.A., et al. Nitric oxide inhalation in infants with respiratory distress syndrome. J Pediatr 130 (1997) 225-230
68. Van Meurs K.P., Rhine W.D., Asselin J.M., et al. Response of premature infants with severe respiratory failure to inhaled nitric oxide. Preemie NO Collaborative Group. Pediatr Pulmonol 24 (1997) 319-323
69. Van Meurs K.P., Wright L.L., Ehrenkranz R.A., et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 353 (2005) 13-22
70. Ballard R.A., Truog W.E., Cnaan A., et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355 (2006) 343-353
71. Schreiber M.D., Gin-Mestan K., Marks J.D., et al. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349 (2003) 2099-2107
72. Subhedar N., and Dewhurst C. Is nitric oxide effective in preterm infants?. Arch Dis Child Fetal Neonatal Ed 92 (2007) F337-F341
73. Barrington K.J., and Finer N.N. Inhaled nitric oxide for preterm infants: a systematic review. Pediatrics 120 (2007) 1088-1099
74. Mestan K.K., Marks J.D., Hecox K., et al. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med 353 (2005) 23-32
75. Kinsella J.P., Walsh W.F., Bose C.L., et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet 354 (1999) 1061-1065
76. Hintz S.R., Van Meurs K.P., Perritt R., et al. Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxide. J Pediatr 151 (2007) 16-22 22.e1-3
77. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. The Franco-Belgium Collaborative NO Trial Group. Lancet 354 (1999) 1066-1071
78. Hascoet J.M., Fresson J., Claris O., et al. The safety and efficacy of nitric oxide therapy in premature infants. J Pediatr 146 (2005) 318-323
79. Field D., Elbourne D., Truesdale A., et al. Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339). Pediatrics 115 (2005) 926-936
80. Dani C., Bertini G., Pezzati M., et al. Inhaled nitric oxide in very preterm infants with severe respiratory distress syndrome. Acta Paediatr 95 (2006) 1116-1123
81. Srisuparp P., Heitschmidt M., and Schreiber M.D. Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome. J Med Assoc Thai 85 Suppl 2 (2002) S469-S478
82. Subhedar N.V., Ryan S.W., and Shaw N.J. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child Fetal Neonatal Ed 77 (1997) F185-F190
83. Subhedar N.V., and Shaw N.J. Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide. Arch Dis Child Fetal Neonatal Ed 77 (1997) F191-F197
84. Bennett A.J., Shaw N.J., Gregg J.E., et al. Neurodevelopmental outcome in high-risk preterm infants treated with inhaled nitric oxide. Acta Paediatr 90 (2001) 573-576
85. Di Fiore J.M., Hibbs A.M., Zadell A.E., et al. The effect of inhaled nitric oxide on pulmonary function in preterm infants. J Perinatol 27 (2007) 766-771
86. Kravitz H., Elegant L.D., Kaiser E., et al. Methemoglobin values in premature and mature infants and children. AMA J Dis Child 91 (1956) 1-5
87. Guthrie S.O., Walsh W.F., Auten K., et al. Initial dosing of inhaled nitric oxide in infants with hypoxic respiratory failure. J Perinatol 24 (2004) 290-294
88. Sokol G.M., Van Meurs K.P., Wright L.L., et al. Nitrogen dioxide formation during inhaled nitric oxide therapy. Clin Chem 45 (1999) 382-387
89. Drury J.A., Nycyk J.A., Subhedar N.V., et al. Inhaled nitric oxide does not increase lipid peroxidation in preterm infants. Eur J Pediatr 157 (1998) 1033
90. Haddad I.Y., Ischiropoulos H., Holm B.A., et al. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 265 (1993) L555-L564
91. Radi R., Beckman J.S., Bush K.M., et al. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288 (1991) 481-487
92. Hallman M., Waffarn F., Bry K., et al. Surfactant dysfunction after inhalation of nitric oxide. J Appl Physiol 80 (1996) 2026-2034
93. Radomski M.W., Palmer R.M., and Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2 (1987) 1057-1058
94. George T.N., Johnson K.J., Bates J.N., et al. The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr 132 (1998) 731-734
95. Hogman M., Frostell C., Arnberg H., et al. Bleeding time prolongation and NO inhalation. Lancet 341 (1993) 1664-1665
96. Cheung P.Y., Salas E., Etches P.C., et al. Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet 351 (1998) 1181-1182
97. Christou H., Magnani B., Morse D.S., et al. Inhaled nitric oxide does not affect adenosine 5′-diphosphate-dependent platelet activation in infants with persistent pulmonary hypertension of the newborn. Pediatrics 102 (1998) 1390-1393
98. Ahluwalia J., Tooley J., Cheema I., et al. A dose response study of inhaled nitric oxide in hypoxic respiratory failure in preterm infants. Early Hum Dev 82 (2006) 477-483
99. Jobe A.J. The new BPD: an arrest of lung development. Pediatr Res 46 (1999) 641-643